Injectable aqueous medicament, containing colloid, e.g. hydroxyethyl starch, to modulate mobility, diffusion, pharmacokinetic and electrophoretic properties of active agent and improve effectiveness

摘要

The use of a colloid (I) is claimed in the preparation of an injectable aqueous medicament, containing at least one active agent (A), for controlling the molecular mobility, diffusion, pharmacokinetic transfer processes and electrophoretic properties of (A), specifically where (I) is administered before, simultaneously with or after the infusion Independent claims are included for the following: (i) the use of an infusible colloid for colloidal 'pharmacomodulation' of (A) in the human or animal body; and (ii) a kit comprising (I) and (A), both in aqueous solution, in spatially separated form.